InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the complete record of transactions filed by Canepa John J, Chief Financial Officer. Director active across 1 company, notably Candel Therapeutics, Inc.. Aggregated, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €68k. History available since 29 July 2021. The latest transaction was filed on 29 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
John J. Canepa is the Chief Financial Officer at Candel Therapeutics, Inc. He oversees the financial management of the company, including planning and financial reporting. His expertise is crucial for the financial health of the business.